Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
29.14
+1.82 (6.66%)
At close: May 12, 2025, 4:00 PM
29.14
0.00 (0.00%)
After-hours: May 12, 2025, 4:38 PM EDT
Agios Pharmaceuticals Employees
As of December 31, 2024, Agios Pharmaceuticals had 488 total employees, including 486 full-time and 2 part-time employees. The number of employees increased by 102 or 26.42% compared to the previous year.
Employees
488
Change (1Y)
102
Growth (1Y)
26.42%
Revenue / Employee
$75,891
Profits / Employee
$1,364,723
Market Cap
1.69B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AGIO News
- 3 days ago - Agios to Present at the 2025 RBC Capital Markets Global Healthcare Conference on May 21, 2025 - GlobeNewsWire
- 10 days ago - Agios to Present at the BofA Securities 2025 Health Care Conference on May 14, 2025 - GlobeNewsWire
- 11 days ago - Agios Pharmaceuticals, Inc. (AGIO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Agios Reports First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 25 days ago - Agios to Webcast Conference Call of First Quarter Financial Results on May 1, 2025 - GlobeNewsWire
- 2 months ago - Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Corporate Development & Strategy Officer - GlobeNewsWire
- 2 months ago - Agios to Present at Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Agios to Present at the TD Cowen 45th Annual Healthcare Conference on March 3, 2025 - GlobeNewsWire